Indunil Karunarathna Explores Clinical and Diagnostic Significance of D-Dimer
Indunil Karunarathna, Founder of Uva Clinical Research Lab (UCRL), shared on LinkedIn:
”Clinical and Diagnostic Significance of D-Dimer From Coagulation Physiology to Multisystem Applications
Uva Clinical Research Lab 2025 Uva Clinical Anaesthesia and Intensive Care ISSN 2827-7198, 2025
D-dimer, a fibrin degradation product, has emerged as a critical biomarker in evaluating thrombotic and fibrinolytic activity within the human body.
Biochemically, D-dimer forms when cross-linked fibrin undergoes plasmin-mediated proteolysis, reflecting the dynamic balance between clot formation and breakdown.
Its high sensitivity and low specificity confer significant clinical utility in ruling out venous thromboembolism (VTE), disseminated intravascular coagulation (DIC), and other hypercoagulable states, though interpretation must be context-specific.
This review provides a comprehensive analysis of the physiological mechanisms of D-dimer formation, the principles of coagulation and fibrinolysis, and the kinetics of its clearance.
We discuss specimen collection, assay methodologies, age-adjusted cutoffs, and factors influencing test accuracy.
Clinical applications are explored in depth, including its role in diagnosing pulmonary embolism, deep vein thrombosis, DIC, stroke, COVID-19–related coagulopathy, and venom-induced consumption coagulopathy.
Integration with risk stratification tools such as the Wells and Geneva scores, as well as the Pulmonary Embolism Rule-out Criteria (PERC), is highlighted to optimize diagnostic pathways.
The review emphasizes both the diagnostic and prognostic implications of D-dimer in diverse patient populations, advocating for judicious use alongside clinical judgment.”
Read the full article here.
Article: Clinical and Diagnostic Significance of D-Dimer From Coagulation Physiology to Multisystem Applications
Authors: Indunil Karunarathna
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 14, 2026, 09:32Kalyan Roy: Swirling as a Simple Indicator of Platelet Quality
-
Apr 14, 2026, 09:26Kausik Ray: How Physicians and Patients Perceive Risk in Lipid Modification Therapy
-
Apr 14, 2026, 09:14Hossam Qassem: When To Start Anticoagulation After Cerebral Aneurysm Clipping
-
Apr 14, 2026, 09:09Kevin Land: Near Elimination of Vaso-Occlusive Crises in Sickle Cell Disease
-
Apr 14, 2026, 07:58Anton Ilich։ A New Test for Rapid Detection of Fibrinolysis in Postpartum Hemorrhage
-
Apr 13, 2026, 17:41Peter Zdziarski: Glanzmann’s Research Foundation Listed as GT Patient Organization on NORD
-
Apr 13, 2026, 17:39Nathan Connell: Why Prophylaxis in vWD Has Historically Lagged Behind Established Practice in Hemophilia
-
Apr 13, 2026, 17:38Tareq Abadl: A Blood Transfusion Can Cause a Delayed Platelet Crash
-
Apr 13, 2026, 13:33Tetsumei Urano: Join for the ISTH Educational Programs at APSTH 2026 in Japan